By contrast, an increasing trend of the percentage of 5hmdC/dC was noted: from 0.0015% in control cells to 0.0025% in 0.5 μM DAC-treated cells, and to 0.0037% in 3 μM DAC-treated cells ( Figure 1f ).
← all excerpts
The hypomethylating agent Decitabine causes a paradoxical increase in 5-hydroxymethylcytosine in human leukemia cells.
1
—
—